Martin D. Abeloff

Decreased Erythropoietin Response in Patients with the Anemia of Cancer

Carole B. Miller, Richard J. Jones, Steven Piantadosi et al. · New England Journal of Medicine · 1990 · 670 citations · Full text

Medicine, Hematology, Oncology +8

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women

I. Craig Henderson, H.T. Mouridsen, O Abe et al. · 1988 · 628 citations

Medicine, Oncology, Breast Oncology +15

Levels of Hypoxia-Inducible Factor-1  During Breast Carcinogenesis

Reinhard Bos, Haining Zhong, Colleen F. Hanrahan et al. · JNCI Journal of the National Cancer Institute · 2001 · 594 citations · Full text

Medicine, Oncology, Pathology +15

HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.

D. Craig Allred, Gary M. Clark, Amol Tandon et al. · Journal of Clinical Oncology · 1992 · 458 citations

Medicine, Oncology, Pathology +14

Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial

Kathy S. Albain, William E. Barlow, Peter M. Ravdin et al. · The Lancet · 2009 · 259 citations · Full text

Medicine, Gynecology, Oncology +17